- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 11.12.25 | Exousia Pro, Inc. Announces Executed LOI for Strategic Acquisition of High-Revenue Telehealth Platform to Accelerate Nutraceutical Commercialization | 358 | ACCESS Newswire | ORLANDO, FL / ACCESS Newswire / December 11, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on proprietary exosome-based delivery systems, is excited to announce... ► Artikel lesen | |
| 05.12.25 | Exousia Pro, Inc. Revolutionizes Nutraceuticals With Launch Of Maxasome: The First All-Natural, Biologically Active Exosomal Supplement | 347 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / December 5, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company leveraging proprietary exosome-based delivery systems, today announced... ► Artikel lesen | |
| 04.12.25 | Renowned Immunologist and Urological Surgeon Dr. Marvin Hausman Featured in New Exousia Bio, Inc. Interview | 1 | GlobeNewswire (USA) | ||
| EXOUSIA Aktie jetzt für 0€ handeln | |||||
| 02.12.25 | Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms | 403 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / December 2, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based delivery systems, today announced the... ► Artikel lesen | |
| 02.12.25 | Exousia Bio, Inc.: LAMY Completes Strategic Acquisition of Cancer Therapy Innovator Exousia AI, Inc. | 280 | GlobeNewswire (Europe) | EXOUSIA AI SECURES HIGH-VALUE ORPHAN DRUG DESIGNATION ORLANDO, Fla., Dec. 02, 2025 (GLOBE NEWSWIRE) -- LAMY, to become Exousia Bio, Inc. (OTCPINK: LMMY) (the "Company" or "Exo Bio"), operating as... ► Artikel lesen | |
| 17.11.25 | Exousia Pro, Inc.: Exousia Pro Initiates Strategic Realignment, Acquires Controlling Stake in SEC-Reporter Lamy in All-stock Exchange Transaction for Exousia AI, to Advance Growth and Enhance Shareholder Value | 432 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / November 17, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based delivery systems, today announced it... ► Artikel lesen | |
| 04.11.25 | Exousia Pro, Inc.: Exousia Pro Announces Breakthrough In Exosome-Based Delivery | 523 | ACCESS Newswire | Successful loading of CBD material accelerates the path to revenue. ORLANDO, FL / ACCESS Newswire / November 4, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company focused... ► Artikel lesen | |
| 28.10.25 | Exousia Pro, Inc.: Exousia Pro is Excited to Announce that it has Received Orphan Drug Designation from the FDA | 368 | ACCESS Newswire | Exousia Pro is in a unique position, as only 11% of ODAs are awarded at the preclinical stage. ORLANDO, FLORIDA / ACCESS Newswire / October 28, 2025 / Exousia Pro, Inc. (formerly Marijuana, Inc.) (OTCPINK:MAJI)... ► Artikel lesen | |
| 29.09.25 | Exousia Pro, Inc.: Exousia Pro Announces Groundbreaking Study to Revolutionize the Global Edibles Market with CBD-Loaded Exosomes | 410 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / September 29, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based therapies, today announced its plan... ► Artikel lesen | |
| 26.09.25 | Exousia Pro, Inc.: Exousia Pro Reports Positive Outcome in Legal Proceeding | 407 | ACCESS Newswire | Focused on Protecting Shareholder Value and Advancing Core Business ORLANDO, FLORIDA / ACCESS Newswire / September 26, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company... ► Artikel lesen | |
| 10.09.25 | Exousia Pro, Inc.: Exousia Pro Files Provisional Patent for Novel Extracellular Vesicle Loading Method, Tapping into Multi-Billion Dollar Markets | 338 | ACCESS Newswire | ORLANDO, FL / ACCESS Newswire / September 10, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company and innovator in exosome-based therapies, today announced a key strategic... ► Artikel lesen | |
| 08.09.25 | Exousia Pro, Inc.: Exousia Pro Announces Strategic Acquisition to Launch a New Telehealth Division | 458 | ACCESS Newswire | Exousia Health is expected to have an initial patient base of 1,000 active clients, projected to generate approximately $50,000 in monthly revenue. ORLANDO, FL / ACCESS Newswire / September 8, 2025... ► Artikel lesen | |
| 03.09.25 | Exousia Pro, Inc.: Exousia Pro Creates New Subdivisions | 456 | ACCESS Newswire | Exousia Pro aims to develop three new subdivisions and launch new products during the 4th quarter.The market for our new products is currently valued at $8.7 billion, projected to grow to $18.5 billion... ► Artikel lesen | |
| 25.06.25 | Marijuana Inc.: Exousia Pro Files Reg A. | 292 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / June 25, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), Exousia Pro, Inc., a clinical-stage biotech company utilizing exosomes in therapies helpful in the treatment of... ► Artikel lesen | |
| 18.06.25 | Marijuana Inc.: Exousia Pro Expands its Scientific Advisory Board | 628 | ACCESS Newswire | Dr. Marvin S. Hausman, MD, will be Chairman of the Scientific Advisory Board. ORLANDO, FLORIDA / ACCESS Newswire / June 18, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotech company... ► Artikel lesen | |
| 30.04.25 | Marijuana Inc.: Exousia Pro Will Launch a Web Series with Our New Consultant | 330 | ACCESS Newswire | Dr. Marvin Hausman is joining Exousia Pro as a Consultant and will host a weekly series. ORLANDO, FL / ACCESS Newswire / April 30, 2025 / MARIJUANA INC. (OTCPINK:MAJI), dba Exousia Pro, Inc., a clinical-stage... ► Artikel lesen | |
| 29.04.25 | Marijuana Inc.: Exousia Pro Finishes Preclinical Trial for Glioblastoma Ahead of Schedule - Bolstering Orphan Drug Application | 358 | ACCESS Newswire | - Rigorous humanized mouse model enhances credibility and translatability of results- Key preclinical data to support FDA Orphan Drug Application- In vitro success signals potential for exosome-based... ► Artikel lesen | |
| 21.04.25 | Marijuana Inc.: Exousia Pro CSO Revealed Significant Findings About the Glioblastoma Study in a Spaces Interview | 424 | ACCESS Newswire | A published paper shows NANOG Expression was almost 100% effective at eradicating tumor cells ORLANDO, FL / ACCESS Newswire / April 21, 2025 / MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc.,... ► Artikel lesen | |
| 17.04.25 | Marijuana Inc.: Exousia Pro Offers Guidance on New Subdivisions | 416 | ACCESS Newswire | ORLANDO, FL / ACCESS Newswire / April 17, 2025 / MARIJUANA INC. (OTCPINK:MAJI), dba Exousia Pro, a clinical-stage biotech company utilizing exosomes in the treatment of cancer and other diseases, is... ► Artikel lesen | |
| 08.04.25 | Marijuana Inc.: Exousia Pro to Deliver 500 Billion Dried Exosomes for Trade Show | 451 | ACCESS Newswire | Exousia Pro has a 60% margin built-in on each order of exosomes ORLANDO, FLORIDA / ACCESS Newswire / April 8, 2025 / MARIJUANA INC. (OTCPINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company... ► Artikel lesen |
1 2 Weiter >>
25 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SARTORIUS AG VZ | 239,60 | -0,91 % | Sartorius: Zurück auf Wachstumskurs - Margen auf Rekordniveau, Ausblick bleibt positiv | Sartorius hat 2025 wie angekündigt wieder deutlich Fahrt aufgenommen: Umsatz und Ergebnis sind spürbar gestiegen, vor allem dank des margenstarken Verbrauchsmaterial-Geschäfts. Auch für 2026 rechnet... ► Artikel lesen | |
| DRONESHIELD | 1,856 | +0,11 % | Paukenschlag und Enttäuschung bei DROHNEN-Plays: Rheinmetall, DroneShield, NEO Battery Materials! | Drohnen gehört die Zukunft. Im militärischen und zivilen Bereich. Daran will auch Rheinmetall teilhaben. Doch der für seine schweren Militärgeräte bekannte größte deutsche Rüstungskonzern musste zuletzt... ► Artikel lesen | |
| SERVE ROBOTICS | 10,675 | +16,16 % | Serve Robotics Partners With Uber To Expand Services To Fort Lauderdale | WASHINGTON (dpa-AFX) - Serve Robotics Inc. (SERV), a sidewalk delivery company, Friday announced that it is partnering with Uber Technologies, Inc. (UBER), the mobility technology major, to... ► Artikel lesen | |
| GPGI | 24,465 | +6,14 % | GPGI, Inc. - 8-K, Current Report | ||
| 2G ENERGY | 35,800 | +5,29 % | ALARM bei Plug Power! 2G Energy und der KI-BOOM! 100 % KURSPOTENZIAL bei der A.H.T. Syngas Aktie! | Über 100 % Kurspotenzial sehen Analysten bei der Aktie von A.H.T. Syngas. Aus Sicht der Experten steht das Unternehmen vor einem Wachstumsschub. Das Marktpotenzial für synthetischen Erdgasersatz aus... ► Artikel lesen | |
| PVA TEPLA | 20,760 | +4,64 % | EQS-News: PVA TePla AG: PVA TePla steigert Auftragseingang 2025 deutlich - moderates Umsatz- und Ergebniswachstum für 2026 erwartet | EQS-News: PVA TePla AG
/ Schlagwort(e): Vorläufiges Ergebnis/Prognose
PVA TePla steigert Auftragseingang 2025 deutlich - moderates Umsatz- und Ergebniswachstum für 2026 erwartet... ► Artikel lesen | |
| UNUSUAL MACHINES | 12,870 | +16,05 % | Unusual Machines, Inc.: Unusual Machines Promotes Drew Camden to President | Expanded role reflects operational scale and execution across U.S. manufacturing ORLANDO, FLORIDA / ACCESS Newswire / February 2, 2026 / Unusual Machines today announced the promotion of Drew Camden... ► Artikel lesen | |
| EVOLV TECHNOLOGIES | 5,480 | +3,79 % | Why Analysts Favor Evolv Technologies (EVLV) | ||
| GEOSPACE TECHNOLOGIES | 10,110 | +7,90 % | GEOSPACE TECHNOLOGIES CORP - 8-K, Current Report | ||
| KLA | 1.219,20 | -0,10 % | KLA Corporation declares $1.90 dividend | ||
| KRATOS DEFENSE | 80,20 | +0,43 % | US-Drohnenprogramm des Kriegsministeriums treibt Aktien von Kratos und Red Cat an | ||
| AXON ENTERPRISE | 349,80 | -0,09 % | Weaker-Than-Expected Margin Hurt Axon Enterprise (AXON) in Q4 | ||
| INNOVATIVE SOLUTIONS & SUPPORT | 19,580 | +8,66 % | IS&S Rebrands to Innovative Aerosystems | New brand identity reflects focus on integrating advanced avionics with intelligent system designs to deliver innovative aerospace solutions
EXTON, Pa.--(BUSINESS WIRE)--Innovative Solutions & Support... ► Artikel lesen | |
| RAIL VISION | 5,800 | +38,42 % | Rail Vision Ltd.: Rail Vision Advances Strategic Collaboration with Israel Railways Cargo Division | With its MainLine product already installed on Israel Railways' locomotives, this collaboration aims to expand Rail Vision's product offering by deploying its ShuntingYard product within Israel Railways'... ► Artikel lesen | |
| CENTROTEC | 62,50 | +4,17 % | EQS-News: CENTROTEC SE: Aktienrückkauf | EQS-News: CENTROTEC SE
/ Schlagwort(e): Aktienrückkauf
Aktienrückkauf
11.08.2025 / 09:01 CET/CEST
Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich.
CENTROTEC... ► Artikel lesen |
EXOUSIA ADVANCED MATERIALS INC gehört der Branche Sonstige Technologie an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu EXOUSIA ADVANCED MATERIALS INC finden Sie auf Wallstreet Online.